Upload Avatar (500 x 500)
Weifeng Ma
maweifeng919@163.com
Chinese, English
Guangdong
Southern Medical University
Public Health
  • Guangzhou Pearl River Science and Technology New Star (2013)
Virus Prevention and Treatment
  • Development of Cas13a-based therapy for cancer treatment, Ying Dong, Bingyang Zhang, Yi Wei, Arkady Murashev, Suihai Wang, Yingsong Wu, Weifeng Ma, Tiancai Liu, 2024
  • PreS/2-21-Guided siRNA Nanoparticles Target to Inhibit Hepatitis B Virus Infection and Replication, Lixia Gao, Jie Yang, Jutao Feng, Ziying Liu, Ying Dong, Jiangyan Luo, Liangzhentian Yu, Jiamei Wang, Hongying Fan, Weifeng Ma, Tiancai Liu, 2022
  • CRISPR-Cas13a-based diagnostic method for Chlamydia trachomatis from nongonococcal urethritis, Kai chen Huang, Hailing Yu, Zhenhua Chen, Guanfeng Lin, Zhigao Zhang, Xiaoyan Zhang, Ying Dong, Hong Chen, Zhen Zhang, Weifeng Ma, Yingsong Wu, Tiancai Liu, 2021
  • Value of Viral Nucleic Acid in Sputum and Feces and Specific IgM/IgG in Serum for the Diagnosis of Coronavirus Disease 2019, Yuwen He, Jiangyan Luo, Jie Yang, Jinlong Song, Li Wei, Weifeng Ma, 2020
  • Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study, Weifeng Ma, Peng Chen, Xiansen Huo, Yufeng Ma, Yanhong Li, Pengcheng Diao, Fang Yang, Shengquan Zheng, Mengjin Hu, Wenwei You, Peiliang Zhao, 2020
  • A Novel CXCR4 Targeting Protein SDF-1/54 as an HIV-1 Entry Inhibitor, Tan S, Li W, Li Z, Li Y, Luo J, Yu L, Yang J, Qiu M, Cheng H, Xu W, Jiang S, Lu L, Liu S, Ma W, 2019
  • Novel [1, 2, 4] triazolo [1, 5-a] pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities, Yang F, Yu LZ, Diao PC, Jian XE, Zhou MF, Jiang CS, You WW, Ma WF, Zhao PL, 2019
Virus Prevention Treatment Covid-19 Hiv Nanomedicine Cytokine Storm Inflammation Cancer Antiviral

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.